Not Available

ADVERTISEMENT

Identification

Molecular formula
C22H26N2O5
CAS Number
Not Available
IUPAC Name
[4-(5-butyl-2,4,6-trioxo-hexahydropyrimidin-1-yl)cyclohexyl] benzoate
Molecular Weight
421.53g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.1900g/cm3
Synonyms
21330-98-3
Interesting facts

Interesting Facts about [4-(5-butyl-2,4,6-trioxo-hexahydropyrimidin-1-yl)cyclohexyl] benzoate

[4-(5-butyl-2,4,6-trioxo-hexahydropyrimidin-1-yl)cyclohexyl] benzoate is a fascinating compound that showcases the intriguing intersection of organic synthesis and medicinal chemistry. Here are some notable aspects of this compound:

  • Unique Structure: The compound features a cyclohexyl ring linked to a benzoate moiety, resulting in an interesting hybrid structure that can lead to unique chemical properties.
  • Potential Biological Activity: Compounds with pyrimidine derivatives have been extensively studied for their biological activities, including antiviral and anticancer properties. This compound may exhibit similar therapeutic potential.
  • Synthetic Versatility: The presence of multiple functional groups allows for further modifications, making it an excellent candidate for a range of synthetic applications.
  • Applications in Drug Discovery: This compound may serve as a lead structure in drug discovery programs aimed at developing new pharmaceuticals.
  • Molecular Connectivity: The integration of different moieties not only enhances potential biological activities but also affects the physicochemical properties, which are critical for drug design and efficacy.

The exploration of compounds like [4-(5-butyl-2,4,6-trioxo-hexahydropyrimidin-1-yl)cyclohexyl] benzoate plays a crucial role in expanding our understanding of medicinal chemistry. As one chemist aptly puts it, "Every compound holds a story, waiting to be discovered." The continuing research in this area underlines the importance of synthesizing novel compounds that could one day lead to breakthroughs in treatment methodologies.

ADVERTISEMENT